Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $870K | ﹤0.01% |
19,332
+3,556
| +23% | +$158K |
|
3252
Tarsus Pharmaceuticals
TARS
$3.05B
| $869K | ﹤0.01% |
59,251
+5,103
| +9% | +$84.4K |
|
3253
FVCBankcorp
FVCB
$340M
| $868K | ﹤0.01% |
56,910
+13,909
| +32% | +$219K |
|
|
CMLS
3254
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $867K | ﹤0.01% |
139,688
+37,960
| +37% | +$271K |
|
3255
NatWest
NWG
$76B
| $866K | ﹤0.01% |
134,006
+38,918
| +41% | +$228K |
|
3256
5E Advanced Materials
FEAM
$67.7M
| $859K | ﹤0.01% |
4,741
+378
| +9% | +$93.3K |
|
|
PSTL
3257
Postal Realty Trust
PSTL
$696M
| $859K | ﹤0.01% |
59,124
-51,909
| -47% | -$791K |
|
|
MACK
3258
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $858K | ﹤0.01% |
74,880
+33,929
| +83% | +$279K |
|
|
SFIX
3259
Stitch Fix
SFIX
$475M
| $857K | ﹤0.01% |
275,569
+3,169
| +1% | +$11.9K |
|
|
CMRX
3260
DELISTED
Chimerix, Inc.
CMRX
| $856K | ﹤0.01% |
460,151
+183,784
| +66% | +$360K |
|
3261
Bakkt Inc
BKKT
$328M
| $856K | ﹤0.01% |
28,765
+3,304
| +13% | +$154K |
|
3262
Third Coast Bancshares
TCBX
$768M
| $854K | ﹤0.01% |
46,352
+7,639
| +20% | +$142K |
|
3263
Baidu
BIDU
$35.1B
| $854K | ﹤0.01% |
7,464
-84,428
| -92% | -$8.62M |
|
|
TSP
3264
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $851K | ﹤0.01% |
519,147
-116,024
| -18% | -$413K |
|
3265
Fossil Group
FOSL
$317M
| $851K | ﹤0.01% |
197,369
-30,038
| -13% | -$126K |
|
3266
Rigel Pharmaceuticals
RIGL
$777M
| $847K | ﹤0.01% |
56,465
-406
| -0.7% | -$3.72K |
|
|
SAL
3267
DELISTED
Salisbury Bancorp, Inc.
SAL
| $846K | ﹤0.01% |
26,939
+704
| +3% | +$19.8K |
|
3268
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$352M
| $845K | ﹤0.01% |
18,073
| – | – |
|
|
FIRY
3269
Firy Inc
FIRY
$148M
| $843K | ﹤0.01% |
83,186
+6,269
| +8% | +$115K |
|
3270
Stoke Therapeutics
STOK
$2B
| $838K | ﹤0.01% |
90,775
+10,595
| +13% | +$110K |
|
3271
PDS Biotechnology
PDSB
$13.3M
| $837K | ﹤0.01% |
63,381
+25,231
| +66% | +$178K |
|
|
HLVX
3272
DELISTED
HilleVax
HLVX
| $835K | ﹤0.01% |
49,921
+8,411
| +20% | +$152K |
|
3273
ArcelorMittal
MT
$55.6B
| $834K | ﹤0.01% |
31,814
+13,086
| +70% | +$321K |
|
3274
Samsara
IOT
$23.4B
| $833K | ﹤0.01% |
67,034
+33,154
| +98% | +$377K |
|
|
BINI
3275
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.